TAO Synergies Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on December 18, 2025, specifically the Company's Annual Meeting of Stockholders. TAO Synergies Inc. (Ticker: TAOX) is an emerging growth company incorporated in Delaware and listed on The Nasdaq Capital Market.
Key Financial Metrics
This filing is a corporate governance report and does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. No financial statements are included in this document.
Material Changes and Voting Results
At the Annual Meeting, a quorum was established with 3,318,341 shares represented (approximately 43.18% of outstanding shares). Stockholders voted on five proposals:
- Proposal 1 (Election of Directors): Bruce T. Bernstein was elected to serve until the 2028 annual meeting. Votes: 1,040,943 For, 74,437 Against, 12,198 Abstentions.
- Proposal 2 (Nasdaq Rule 5635(d) Approval): Stockholders approved the issuance of common stock underlying convertible preferred stock and warrants issued under a Securities Purchase Agreement dated October 13, 2025, and an engagement letter with GP Nurmenkari Inc. This issuance exceeds 20% of the pre-issuance outstanding common stock. Votes: 504,481 For, 78,798 Against, 2,109 Abstentions.
- Proposal 3 (Equity Incentive Plan Amendment): Stockholders approved an amendment to the 2020 Equity Incentive Plan to increase the share reserve by 500,000 shares, bringing the total to 3,175,000 shares. Votes: 994,315 For, 110,637 Against, 22,626 Abstentions.
- Proposal 4 (Auditor Ratification): StephanoSlack LLC was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Votes: 3,241,023 For, 22,536 Against, 54,782 Abstentions.
- Proposal 5 (Adjournment): Stockholders approved the authority to adjourn the meeting to solicit additional proxies if necessary. Votes: 3,210,518 For, 150,935 Against, 46,883 Abstentions.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, outlook, or specific risk factors. The primary operational update is the authorization of significant equity issuance (Proposal 2) and the expansion of the equity incentive pool (Proposal 3).
Investor Verification Checklist
- Verify the terms of the Securities Purchase Agreement dated October 13, 2025, specifically regarding the convertible preferred stock and warrants referenced in Proposal 2.
- Review the full text of the Amended and Restated 2020 Equity Incentive Plan (Exhibit 10.1) to understand vesting schedules and dilution implications of the 500,000 share increase.
- Confirm the total number of shares outstanding post-issuance to assess the dilution impact of the 20%+ issuance approved in Proposal 2.
- Check subsequent filings for the actual issuance date and pricing of the convertible securities authorized in Proposal 2.